Skip to content

MoST Core Studies (C1)

Strictly PrivateGoverned by: Not applicable - public program
UntestedNeeds reviewCommunity verifiedLocal
computedPrimary intervention/evidence/outcome/context records are authoritative; portfolio score is currently computed heuristic output.
Therapeutic
Delivered by

Australian Genomic Cancer Medicine Centre Limited

YouthLarge ACNC charityHealth
Location
NSW · 2052
LGA
Sydney
Remoteness
Major Cities of Australia
ABN
67627640733

About This Intervention

Core clinical trials within the MoST program focused on matching therapies to genomic profiles....

Portfolio Score

0

Overall Score

Evidence Strength0%
Community Authority0%(weight: 30%)
Harm Risk100%
Implementation Capability0%
Option Value0%
TierNeeds Development

Recommendations

  • Would benefit from formal evaluation or RCT validation
  • Needs further development before replication
  • Elevated harm risk — requires careful monitoring